Evaluation of an Oral Nutritional Supplement With a New Protein Blend

Abbott Nutrition1 site in 1 country25 target enrollmentOctober 2012

ConditionsGastro-intestinal Tolerance

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Gastro-intestinal Tolerance
Sponsor: Abbott Nutrition
Enrollment: 25
Locations: 1
Primary Endpoint: Gastro-Intestinal Tolerance
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to evaluate gastrointestinal tolerance of an oral nutritional supplement containing a new protein blend in healthy elderly subjects.

Registry

clinicaltrials.gov

Start Date

October 2012

End Date

November 2012

Last Updated

13 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Abbott Nutrition

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subjects will be eligible for the study if they meet all of the following inclusion criteria:
•Age ≥ 60 and ≤ 90 years
•Body Mass Index (BMI) \> 20 but \< 35

Exclusion Criteria

•Subjects will be excluded from the study if they meet any of the following criteria:
•History of diabetes
•Currently taking or has taken antibiotic within 1 week prior to enrollment
•Major surgery less than 3 months prior to enrollment in the study
•Current active malignant disease or was treated within the last 6 months for cancer
•Immunodeficiency disorder
•Myocardial infarction within the last 3 months prior to enrollment
•Chronic obstructive pulmonary disease (COPD)
•Allergy to any of the ingredients in the study product
•Aversion to flavor of product being tested